Thus, individuals with impaired glucose tolerance or diabetes mellitus have reduced NK cell activity, which might help to explain why patients with diabetes mellitus are more susceptible to COVID-19 and have a worse prognosis than those without diabetes mellitus
Thus, it is necessary to address the problem as soon as it is identified
Note: The ready-to-use DTNB Reagent is supplied with sufficient volume to perform one 4-VP verification
Kenyon, C., Chang, J., Gensch, E., Rudner, A
Overall, the use of metformin as an adjunct treatment for AN, particularly in patients with underlying hyperglycemia, is supported in the literature, but further studies are needed to clarify dosing, duration of therapy, and patient populations that will benefit most from adding metformin to their treatment regimens